Utah Medical Products Inc. (UTMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Utah Medical Products Inc...

    NASDAQ: UTMD · Real-Time Price · USD
    62.81
    -0.20 (-0.32%)
    At close: Sep 25, 2025, 10:17 AM

    Utah Medical Products Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 40.9M 50.22M 52.28M 49.05M
    Cost of Revenue
    		 16.76M 20.19M 20.09M 18.14M
    Gross Profit
    		 24.14M 30.04M 32.2M 30.92M
    Operating Income
    		 13.59M 16.78M 19.79M 18.88M
    Interest Income
    		 n/a n/a n/a 166K
    Pretax Income
    		 16.8M 20.09M 20.66M 19.06M
    Net Income
    		 13.87M 16.64M 16.47M 14.79M
    Selling & General & Admin
    		 5.53M 12.7M 11.91M 11.51M
    Research & Development
    		 813K 560K 493K 526K
    Other Expenses
    		 n/a n/a n/a 15K
    Operating Expenses
    		 10.55M 13.26M 12.41M 12.04M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 1.9M 1.69M 1.51M 1.41M
    Cost & Expenses
    		 27.31M 33.45M 32.49M 30.17M
    Income Tax Expense
    		 2.93M 3.45M 4.19M 4.27M
    Shares Outstanding (Basic)
    		 3.5M 3.64M 3.64M 3.65M
    Shares Outstanding (Diluted)
    		 3.5M 3.64M 3.64M 3.66M
    EPS (Basic)
    		 3.96 4.57 4.53 4.05
    EPS (Diluted)
    		 3.96 4.57 4.52 4.04
    EBITDA
    		 16.44M 24.75M 26.87M 26.16M
    EBIT
    		 13.59M 18.44M 19.79M 18.88M
    Depreciation & Amortization
    		 2.77M 6.37M 7.08M 7.28M

    Add to Watchlist